These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Improving compliance with the C. difficile root cause analysis tool to reduce incidence. Owen L. Nurs Times; 2015 Apr; 105(16):14-6. PubMed ID: 19480159 [Abstract] [Full Text] [Related]
47. Rapid spread of methicillin-resistant Staphylococcus aureus in a new hospital in the broad-spectrum antibiotic era. Lee SS, Kim HS, Kang HJ, Kim JK, Chung DR. J Infect; 2007 Oct; 55(4):358-62. PubMed ID: 17692383 [Abstract] [Full Text] [Related]
49. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. Ludlam H, Brown N, Sule O, Redpath C, Coni N, Owen G. Age Ageing; 1999 Oct; 28(6):578-80. PubMed ID: 10604512 [Abstract] [Full Text] [Related]
50. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, Wille JC, Gyssens IC. J Antimicrob Chemother; 2005 Dec; 56(6):1094-102. PubMed ID: 16234334 [Abstract] [Full Text] [Related]
52. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Mahamat A, MacKenzie FM, Brooker K, Monnet DL, Daures JP, Gould IM. Int J Antimicrob Agents; 2007 Aug; 30(2):169-76. PubMed ID: 17560085 [Abstract] [Full Text] [Related]
53. Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). Corona A, Bertolini G, Lipman J, Wilson AP, Singer M. J Antimicrob Chemother; 2010 Jun; 65(6):1276-85. PubMed ID: 20335186 [Abstract] [Full Text] [Related]
57. Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change. Schwartzberg E, Rubinovich S, Hassin D, Haspel J, Ben-Moshe A, Oren M, Shani S. J Clin Pharm Ther; 2006 Apr; 31(2):179-85. PubMed ID: 16635053 [Abstract] [Full Text] [Related]
59. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Valiquette L, Cossette B, Garant MP, Diab H, Pépin J. Clin Infect Dis; 2007 Sep 01; 45 Suppl 2():S112-21. PubMed ID: 17683015 [Abstract] [Full Text] [Related]